Arbet-Engels Christophe
SEC CIK 1802615 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | Chief Medical Off | 864.2K | — | $5,231 | 3 | 2025-01-23 | 2025-02-12 |
Most active insiders at XFOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Craig Adam R | Executive COB, Dir | $250.0K | $210.8K |
| 2 | KIRSKE DAVID | CFO | — | $109.2K |
| 3 | Volpone John | Pres | — | $109.2K |
Arbet-Engels Christophe made no open-market trades at XFOR in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-12 | XFOR | X4 Pharmaceuticals, Inc | Arbet-Engels Christophe | Chief Medical Off | A - Grant | $0.00 | +850.0K | 864.2K | +5,983% | $0 | |
| 2025-01-27 | 2025-01-23 | XFOR | X4 Pharmaceuticals, Inc | Arbet-Engels Christophe | Chief Medical Off | A - Grant | $0.00 | +25.8K | 25.8K | New | $0 | |
| 2025-01-27 | 2025-01-24 | XFOR | X4 Pharmaceuticals, Inc | Arbet-Engels Christophe | Chief Medical Off | S - Sale | $0.45 | -11.6K | 14.2K | -45% | -$5,231 |
Purchase Sale Sale after option exercise All abbreviations